Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Peng, Shih Yi ^a   You, Ren In ^a   Lai, Meng Jiun ^a   Lin, Nien Tsung ^a   Chen, Li Kuang ^b   Chang, Kai Chih ^a,b  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; ANTIMICROBIAL CATIONIC PEPTIDE; ENDOLYSIN; ENDOTOXIN; PROTEINASE; VIRAL PROTEIN;

ACINETOBACTER BAUMANNII; ANIMAL; BACTERIOPHAGE; BIOSYNTHESIS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CHEMISTRY; ELECTRON MICROSCOPY; HEMOLYSIS; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST; MOUSE; PHYSIOLOGY; ULTRASTRUCTURE; VIROLOGY;

ACINETOBACTER BAUMANNII; ADENOSINE MONOPHOSPHATE; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIOPHAGES; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; ENDOPEPTIDASES; ENDOTOXINS; HEMOLYSIS; HUMANS; MICE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON; VIRAL PROTEINS;

EID: 85029286330     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-11832-7     Document Type: Article

References (26)

1. Perez, F. et al. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51, 3471-3484, doi: https://doi.org/10.1128/AAC.01464-06 (2007).
2. Garnacho-Montero, J. & Amaya-Villar, R. Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr Opin Infect Dis 23, 332-339, doi: https://doi.org/10.1097/QCO.0b013e32833ae38b (2010).
3. Hancock, R. E. & Sahl, H. G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24, 1551-1557, doi: https://doi.org/10.1038/nbt1267 (2006).
4. Gentilucci, L., Tolomelli, A. & Squassabia, F. Peptides and peptidomimetics in medicine, surgery and biotechnology. Curr Med Chem 13, 2449-2466 (2006).
5. Melo, M. N., Ferre, R. & Castanho, M. A. Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations. Nat Rev Microbiol 7, 245-250, doi: https://doi.org/10.1038/nrmicro2095 (2009).
6. Wang, J. et al. Ancient antimicrobial peptides kill antibiotic-resistant pathogens: Australian mammals provide new options. PLoS One 6, e24030, doi: https://doi.org/10.1371/journal.pone.0024030 (2011).
7. Wang, G., Li, X. & Wang, Z. APD3: the antimicrobial peptide database as a tool for research and education. Nucleic Acids Res 44, D1087-1093, doi: https://doi.org/10.1093/nar/gkv1278 (2016).
8. O'Flaherty, S., Ross, R. P. & Coffey, A. Bacteriophage and their lysins for elimination of infectious bacteria. FEMS Microbiol Rev 33, 801-819, doi: https://doi.org/10.1111/j.1574-6976.2009.00176.x (2009).
9. Lood, R. et al. Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model. Antimicrob Agents Chemother 59, 1983-1991, doi: https://doi.org/10.1128/AAC.04641-14 (2015).
10. Vaara, M. Agents that increase the permeability of the outer membrane. Microbiol Rev 56, 395-411 (1992).
11. During, K., Porsch, P., Mahn, A., Brinkmann, O. & Gieffers, W. The non-enzymatic microbicidal activity of lysozymes. FEBS Lett 449, 93-100 (1999).
12. Orito, Y., Morita, M., Hori, K., Unno, H. & Tanji, Y. Bacillus amyloliquefaciens phage endolysin can enhance permeability of Pseudomonas aeruginosa outer membrane and induce cell lysis. Appl Microbiol Biotechnol 65, 105-109, doi: https://doi.org/10.1007/s00253-003-1522-1 (2004).
13. Lai, M. J. et al. Identification and characterisation of the putative phage-related endolysins through full genome sequence analysis in Acinetobacter baumannii ATCC 17978. Int J Antimicrob Agents 42, 141-148, doi: https://doi.org/10.1016/j.ijantimicag.2013.04.022 (2013).
14. Lai, M. J. et al. Antibacterial activity of Acinetobacter baumannii phage varphiAB2 endolysin (LysAB2) against both gram-positive and gram-negative bacteria. Appl Microbiol Biotechnol 90, 529-539, doi: https://doi.org/10.1007/s00253-011-3104-y (2011).
15. Powers, J. P. & Hancock, R. E. The relationship between peptide structure and antibacterial activity. Peptides 24, 1681-1691, doi: https://doi.org/10.1016/j.peptides.2003.08.023 (2003).
16. Reddy, K. V., Yedery, R. D. & Aranha, C. Antimicrobial peptides: premises and promises. Int J Antimicrob Agents 24, 536-547, doi: https://doi.org/10.1016/j.ijantimicag.2004.09.005 (2004).
17. Thandar, M. et al. Novel Engineered Peptides of a Phage Lysin as Effective Antimicrobials against Multidrug-Resistant Acinetobacter baumannii. Antimicrob Agents Chemother 60, 2671-2679, doi: https://doi.org/10.1128/AAC.02972-15 (2016).
18. Garidel, P. a. B., Klaus. Current Understanding of Polymyxin B Applications in Bacteraemia/Sepsis Therapy. Prevention: Clinical, Pharmaceutical, Structural and Mechanistic Aspects. Anti-Infective Agents in Medicinal Chemistry 8, 367-385, doi: https://doi.org/10.2174/187152109789760171 (2009).
19. Reis, A. O., Luz, D. A., Tognim, M. C., Sader, H. S. & Gales, A. C. Polymyxin-resistant Acinetobacter spp. isolates: what is next? Emerg Infect Dis 9, 1025-1027, doi: https://doi.org/10.3201/eid0908.030052 (2003).
20. Fernandez, L. et al. Characterization of the polymyxin B resistome of Pseudomonas aeruginosa. Antimicrob Agents Chemother 57, 110-119, doi: https://doi.org/10.1128/AAC.01583-12 (2013).
21. Wang, G., Li, X. & Wang, Z. APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res 37, D933-937, doi: https://doi.org/10.1093/nar/gkn823 (2009).
22. Malanovic, N. & Lohner, K. Gram-positive bacterial cell envelopes: The impact on the activity of antimicrobial peptides. Biochim Biophys Acta 1858, 936-946, doi: https://doi.org/10.1016/j.bbamem.2015.11.004 (2016).
23. Brandenburg, K., Heinbockel, L., Correa, W. & Lohner, K. Peptides with dual mode of action: Killing bacteria and preventing endotoxin-induced sepsis. Biochim Biophys Acta 1858, 971-979, doi: https://doi.org/10.1016/j.bbamem.2016.01.011 (2016).
24. JB, P. CLSI Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement. (2015).
25. Conlon, J. M., Ahmed, E., Pal, T. & Sonnevend, A. Potent and rapid bactericidal action of alyteserin-1c and its [E4K] analog against multidrug-resistant strains of Acinetobacter baumannii. Peptides 31, 1806-1810, doi: https://doi.org/10.1016/j.peptides.2010.06.032 (2010).
26. Tian, Z. G., Dong, T. T., Teng, D., Yang, Y. L. & Wang, J. H. Design and characterization of novel hybrid peptides from LFB15(W4,10), HP(2-20), and cecropin A based on structure parameters by computer-aided method. Appl Microbiol Biotechnol 82, 1097-1103, doi: https://doi.org/10.1007/s00253-008-1839-x (2009).